The global cancer cachexia market demonstrates a considerably high
competition among the leading players, finds a new research report by
Transparency Market Research (TMR). The key vendors of cancer
cachexia treatment solutions, globally, are actively involving in
partnerships, mergers, and acquisitions with clinical trial companies
in a bid to strengthen their product portfolios. They are likely to
focus more on technological upgrades and introducing new therapeutics
based on appetite stimulation mechanism of action for the treatment
of cancer cachexia in the near future, as it will be the new trend in
this market. The key participants operating in this market are Æterna
Zentaris Inc., Aphios Corp., Alder BioPharmaceuticals Inc., Eli Lilly
and Co., Helsinn Group, GTx Inc., Merck & Co. Inc., Bristol-Myers
Squibb Co., Novartis AG, and XBiotech Inc., states the research
report.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15482
According to the research report, the global market for cancer
cachexia was worth US$1.63 bn in 2016. Research analyst at TMR expect
the opportunity in this market to rise at a CAGR of 4.90% during the
period from 2017 to 2025 and reach a value of US$2.51 bn by the end
of the period of the forecast. Among the therapeutics available for
the treatment of cancer cachexia, the demand for progestogens is
comparatively higher and is expected to remain so over the next few
years, thanks to their efficiency. Regionally, the market is led by
North America. Researchers project this regional market to continue
on the top in the near future on account of the rising awareness
among people regarding cancer supportive care, notes the market
study.
The increasing prevalence of cachexia, especially in industrialized
regions, such as North America, Europe, and Japan, is the main factor
behind the significant growth of the market for cancer cachexia,
worldwide. According to an estimation, currently, cachexia affects
around nine million patients, globally, which is round about 1% of
overall patient-pool across the world. This factor is expected to
create more opportunities for existing participants and players,
looking to enter the market over the next few years.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=15482
The strong product pipeline is another important factor that will
support the growth of this market in the near future. “With a
promising clinical pipeline and imminent regulatory approvals, the
global market for cancer cachexia is likely to report a substantial
growth in the years to come, states the author of the research
study.
Although the worldwide market for cancer cachexia points towards a
thriving future; its growth trajectory will not be smooth enough. The
stringent regulatory requirements and the long procedure for FDA
approval may dissuade the manufacturers of cancer cachexia drugs from
investing in this market over the forthcoming years, which, in turn,
will impede the growth of this market in the long run, states the
research report.
Report Overview @
https://www.transparencymarketresearch.com/cancer-cachexia-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment